Calendar · pharmadog

Sign In Subscribe

Week of Jan 12, 2026

30

Jan 16, 2026approval210d agoZYNLONTA (LONCASTUXIMAB TESIRINE-LPYL) — FDA approvalloncastuximab tesirine

Sponsor: ADC Therapeutics SA. Form: INJECTABLE. Route: INJECTION

full page →loncastuximab tesirine →fda approvals ↗

Jan 16, 2026approval210d agoBRIUMVI (UBLITUXIMAB-XIIY) — FDA approvalublituximab

Sponsor: TG THERAPEUTICS, INC. Form: INJECTABLE. Route: INTRAVENOUS

full page →ublituximab →fda approvals ↗

Jan 16, 2026approval210d agoLEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

full page →lecanemab →fda approvals ↗

Jan 16, 2026approval210d agoRYKINDO (RISPERIDONE) — FDA approvalDelpor Inc

Sponsor: SHANDONG LUYE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →fda approvals ↗

Jan 16, 2026approval210d agoIMPLANON (ETONOGESTREL) — FDA approvaletonogestrel CR

Sponsor: ORGANON. Form: IMPLANT. Route: IMPLANTATION

full page →etonogestrel CR →fda approvals ↗

Jan 16, 2026approval210d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗

Jan 16, 2026approval210d agoLOSARTAN POTASSIUM — FDA approvalLOSARTAN POTASSIUM

Sponsor: HIKMA. Form: TABLET. Route: ORAL

full page →LOSARTAN POTASSIUM →fda approvals ↗

Jan 16, 2026approval210d agoPRUCALOPRIDE SUCCINATE — FDA approvalPRUCALOPRIDE SUCCINATE

Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL

full page →PRUCALOPRIDE SUCCINATE →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalPrasco LLC

Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalPrasco LLC

Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalPrasco LLC

Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalPrasco LLC

Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalPrasco LLC

Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoPOTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (POTASSIUM CHLORIDE) — FDA approvalUpsher-Smith Laboratories LLC

Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 17, 2026approval209d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 18, 2026approval208d agoTOPIRAMATE — FDA approvaltopiramate ER

Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

full page →topiramate ER →fda approvals ↗

Jan 18, 2026approval208d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 18, 2026approval208d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 18, 2026approval208d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: MYLAN. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Jan 18, 2026approval208d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Week of Jan 19, 2026

20

Jan 19, 2026approval207d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Jan 19, 2026approval

← prev

page 1 of 22